产品目录
| 编号 | 化学名称 | Cas号 | 纯度 | 化学结构 |
|---|---|---|---|---|
| 20264 | ALC-0315 | 2036272-55-4 | 98% Min. |  |
| ALC-0315 is a synthetic cationic lipid (or ionizable lipid). It is a colorless oily m | ||||
| 2105071 | AP1189 acetate | 959850-74-9 | ≧98.0% |  |
| AP1189 is a melanocortin receptor agonist on MC1 and MC3 receptors. | ||||
| 21223 | AMG-221 | 1095565-81-3 | 98% Min. |  |
| AMG-221, BVT-83370, is a potent and selective 11β-HSD1 inhibitor. AMG-221 decreased | ||||
| 20211801 | ACT-389949 (ACT389949) | 1258417-54-7 | 98% Min. | _1258417-54-7.png) |
| ACT-389949 is a potent and selective agonist of formyl peptide receptor type 2 (FPR2) | ||||
| 20111201 | AT-56 | 162640-98-4 | 98% Min. |  |
| AT-56 is a selective, competitive, and highly bioavailable inhibitor of lipocalin-typ | ||||
| 20103001 | ASN007 | 2055597-12-9 | ≧98.0% |  |
| ASN007 , a novel oral ERK inhibitor , has shown anti-tumor activity in both solid tum | ||||
| 2091501 | AB-680 | 2105904-82-1 | 98% Min. |  |
| AB-680一种是高效、可逆和选择性CD73抑制剂。AB-680是第一个临床使 | ||||
| 23948 | Apilimod mesylate ( STA-5326 ) | 870087-36-8 | ≧98.0% | _870087-36-8.png) |
| Apilimod, also known as STA-5326, is a potent IL-12/IL-23 inhibitor. Apilimod inhibit | ||||
| 2071801 | AVN-101 HCl | 1061354-48-0 | 98% |  |
| AVN-101是一种非常有效的5-HT7受体拮抗剂（Ki = 153 pM），对5-HT6、5-H | ||||
| 2071628 | APX-115 freebase | 1270084-92-8 | 98% Min. |  |
| 2071626 | Apcin | 300815-04-7 | 98% Min. |  |
| Apcin is an inhibitor of the anaphase-promoting complex/cyclosome (APC/C). It acts by | ||||
| 2071552 | Astemizole | 68844-77-9 | 98% Min. |  |
| Astemizole is a histamine H1-receptor antagonist. Astemizole competitively binds to h | ||||
| 2071539 | ARV-771 | 1949837-12-0 | 98% Min. |  |
| ARV-771 is a small-molecule pan-BET degrader. ARV-771 demonstrates dramatically impro | ||||
| 2071531 | AZD-7648 | 2230820-11-6 | 98% Min. |  |
| AZD-7648 is a potent and selective DNA-PK inhibitor. | ||||
| 2071530 | AWZ1066S | 239272-16-1 | 98% Min. |  |
| AWZ1066S is a highly specific anti-Wolbachia drug candidate for a short-course treatm | ||||
| 2071523 | AER-271 | 634913-39-6 | 98% Min. |  |
| AER-271 is a potent aquaporin-4 (AQP4) inhibitor. AER-271 blocks acute cerebral edema | ||||
| 2071517 | ABX-1431 | 1446817-84-0 | 98% Min. |  |
| ABX-1431 is a covalent, irreversible MGLL inhibitor. ABX-1431 is currently entering c | ||||
| 2071508 | AZ31 | 2088113-98-6 | 98% Min. |  |
| AZ31 is a potent and highly selective ATM inhibitor. | ||||
| 2071503 | AB-423 | 1572510-80-5 | 98% Min. |  |
| AB-423 is a novel inhibitor of hepatitis b virus pregenomic rna encapsidation | ||||
| 202323 | 2-aminopyrazolo[1,5-a]pyridine-3-carboxylic acid | 1542020-25-6 | 98% Min. |  |
| 2062319 | 1-acetyl-5-nitro-3H-indol-2-one | 114985-63-6 | 98% Min. | |
| 2061313 | 1-acetyl-5-amino-2-indolinone | 422518-10-3 | 98% Min. | |
| 2062312 | (4aS,9bR)-Ethyl 6-bromo-5-(2-(methylamino)-2-oxoethyl)-3,4,4a,5-tetrahydro-1H-pyrido[4,3-b]indole-2(9bH)-carboxylate | 2098497-32-4 | 98% Min. | |
| 2062311 | 8-Acetyl-5-(benzyloxy)-2H-benzo[b][1,4]oxazin-3(4H)-one | 1035299-32-3 | 98% Min. | |
| 2062307 | 2-Amino-5-cyanopyrazine | 113305-94-5 | 98% Min. | |
| 2062025 | 5-amino-3,4-dimethylthieno[2,3-c]pyridazine-6-carboxylic acid | 1452226-14-0 | 96% Min. |  |
| 2062009 | AT13148 intermediate(N1) | 1056901-64-4 | 96% Min. |  |
| 2061701 | Anacetrapib | 875446-37-0 | 98% Min. |  |
| Anacetrapib, also known as MK-0859, is a CETP inhibitor being developed to treat hype | ||||
| 2061308 | Ambrisentan | 177036-94-1 | 98% Min. |  |
| Ambrisentan, also known as BSF-208075 and LU-208075, is a drug indicated for use in t | ||||
| 206101 | CS-2696 | 2097416-76-5 | 98% Min. | |
| AZD-0364 is a potent and selectiveERK2inhibitor extracted from patent WO2017080979A1, | ||||